不久前，大连海关所属大连邮局海关查验关员在对进境国际邮件进行查验时，查获一箱申报为"折纸艺术、杂志"的活体蜘蛛，经现场清点，共计504 只。经专业机构鉴定，该活体蜘蛛为委内瑞拉太阳虎（Psalmopoeus irminia），为大连海关首次截获。该查获案例获评"2025年海关查获外来物种十大案 例"。 大连海关所属大连邮局海关检疫监管科副科长熊国华介绍，近年来，一些追求时尚、新潮的宠物爱好者，不再满足于饲养传统的猫狗宠物，转而饲 养"异宠"。而异宠多为外来物种，一旦逃逸或被遗弃到自然界，可能因缺乏天敌挤压本土物种的生存空间，破坏生态平衡和影响生物多样性。我国已发现 660多种外来入侵物种，其中71种对自然生态系统造成或具有潜在威胁，59种被列入《重点管理外来入侵物种名录》实施重点管控，这些物种每年造成的经 济损失超1200亿元。 胡强介绍，一些"异宠"可能具有攻击性和毒性，也可能携带多种病原微生物，给人类健康造成严重甚至致命的影响。此次截获的委内瑞拉太阳虎性格凶 猛，移动速度快，攻击性强，具有较强的毒性，可能对某些体质过敏的人造成严重后果。据报道，2023年6月一名美国35岁男性在清洁饲养箱时被委内瑞拉 太阳 ...

Core Viewpoint - Intellectual property has become a critical strategic resource for countries amid the accelerated restructuring of the global pharmaceutical supply chain and increasing technological competition [1] Group 1: Importance of Intellectual Property in Pharmaceuticals - The pharmaceutical industry in China is at a crucial stage of innovation transformation and international expansion [1] - Strengthening sovereignty over intellectual property in the pharmaceutical sector is vital for balancing development and security, promoting high-level technological self-reliance, ensuring public health, and safeguarding national long-term interests [4] Group 2: Recommendations for Intellectual Property Sovereignty Strategy - A proposal has been made to implement a pharmaceutical intellectual property sovereignty strategy, emphasizing top-level design and coordination [4] - Key areas, core objectives, and strategic paths for maintaining intellectual property sovereignty should be integrated into the overall layout of biological safety and technological innovation [4] - Establishing a provincial risk review and early warning mechanism for pharmaceutical intellectual property sovereignty is recommended, involving regular collaboration among intellectual property, drug regulation, technology, and commerce departments [4] Group 3: Legal and Regulatory Enhancements - There is a need to improve laws and regulations to strengthen the "firewall" of sovereignty, including clarifying core pharmaceutical technology export control lists and cross-border data flow safety management in relevant laws [4] - The proposal includes setting baseline requirements for the ownership of intellectual property in collaborative research outcomes [4] Group 4: International Standards Participation - Support for enterprises or institutions to lead or participate in the formulation of international standards, particularly in new therapies and digital healthcare, is suggested [5] - The aim is to incorporate independent intellectual property technologies into international standard systems to enhance China's substantive participation in rule-making [5]

Core Viewpoint - The construction of a comprehensive foreign-related legal system is essential for advancing China's modernization and ensuring a favorable legal environment for international engagement [2][3]. Group 1: Foreign-related Legislation - The goal of foreign-related legal construction is to establish a systematic and complete foreign-related legal framework, which is a complex and long-term project [3]. - Significant progress has been made in foreign-related legislation over the past five years, including the enactment of laws such as the Anti-Foreign Sanctions Law and the Foreign Relations Law [3][4]. - The focus during the 14th Five-Year Plan period will be on legislation in key areas such as national security, technology innovation, public health, and ecological civilization [4]. Group 2: Law Enforcement System - The effectiveness of laws relies on their implementation, and strict law enforcement is crucial for maintaining the authority and seriousness of foreign-related laws [5][6]. - Recent measures have significantly improved foreign-related law enforcement capabilities, particularly in countering unilateral sanctions and enhancing export control [6]. - There is a need for further reform in the foreign-related law enforcement system to address issues of non-compliance and improve transparency [6]. Group 3: Judicial System - The quality of foreign-related judicial work has steadily improved, with ongoing optimization of foreign-related trial systems and increased international judicial cooperation [7][8]. - Enhancing the credibility of foreign-related judicial processes is a priority, necessitating reforms to improve efficiency and fairness [8]. Group 4: Legal Awareness and Compliance - Promoting legal awareness among enterprises and citizens is vital for the construction of a rule-of-law society, especially for those engaging internationally [9][10]. - There has been significant progress in legal education and training for leaders and key personnel involved in international business [9]. Group 5: Legal Services System - The development of a robust foreign-related legal services industry is urgent, with a focus on international commercial arbitration as a primary method for resolving cross-border disputes [12][13]. - The current state of foreign-related legal services is underdeveloped, and there is a need for improved internationalization of legal practices [12]. Group 6: Talent Development - The cultivation of high-quality, internationalized legal professionals is essential for supporting the rule of law in foreign-related contexts [14][15]. - Educational reforms and targeted policies are being implemented to enhance the training of legal talent in foreign-related law [14]. Group 7: International Cooperation - Strengthening international law enforcement and judicial cooperation is crucial for protecting national interests and enhancing global governance [16][17]. - Future efforts will focus on improving judicial assistance mechanisms and expanding international cooperation in combating transnational crime [17].

整场直播听下来呢，奥特曼也确实给出了一些非常实诚的结论，我也帮大家小小总结了一下： 未来从事工程师工作的人数可能会大幅增加。 我们花在写代码、调试代码上的时间将会明显减少，更多精力会用在让系统替我们把事办成上。 问题一个比一个劲爆，奥特曼这边也是诚意满满，主打一个：奥特曼大舞台，有问题您就来～ 在今后的几年，我们会大量使用只为一个人、或极小群体量身定制的软件。 大家是真敢问，奥特曼也是真敢说！ 刚刚，奥特曼拉着一屋子AI相关从业者搞了一场直播，围绕软件工程、商业、模型开发、科学研究、教育、安全等问题，奥特曼进行了一场超「有问必 答」的对谈。 OpenAI确实搞砸了ChatGPT5系列模型，今后ChatGPT也一定会回到真正的通用模型上。 在接下来的几年里，模型学习新技能的速度会比人类还要快。 以下为本场直播的重点内容实录，围绕核心观点做了摘选整理，部分文字在不改变原意的基础上做了适度删改～ AI 正在重新定义工作、技术和教育这三件事 Q：如果AI让写代码这事儿变得又快又便宜，那是不是意味着未来市场会减少对软件工程师的需求？ Sam Altman:我认为，未来从事工程师工作的人数可能会「大幅增加」。 不仅如此， ...

市疾控中心副主任吴寰宇同步解读三大重点项目成效。他说，在传染病防控领域，上海构建"监测—预 警—处置"闭环，制定发热及肠道门诊地方标准，实现数据全采集，首创"社区+医院"双轨监测模式，建 立1.5万人社区队列。AI预警模型可提前2周预判疫情及医疗负荷，评估精度达街镇级，为冬春季流感防 控提供支撑；气象预警技术入选世卫案例，后续将发布感冒指数。建成一流应急作业中心，5G技术赋 能流调，实现现场与指挥中心实时联动。 在生物安全领域，实现病原检测溯源突破，云端研判系统构建生物样本数字信息库，可48小时定位未知 病原、24小时完成30例样本溯源，同步搭建"微生物资源共享超市"。形成"申"字形实验室网络，以市疾 控为核心、6家区疾控为枢纽，统一标准实现检测同质化。构建"人—动物—环境"监测网，耐药基因监 测覆盖排水系统，气传微生物监测延伸至重点场所，类器官平台助力生物医药创新。 本轮重点推进四大工程：应急能力上，构建智能传染病监测预警与响应体系，完善平急结合救治体系， 布局传染病临床诊治中心（IDC）体系；服务能力上，优化市区疾控实验室布局，打造传染病防治监管 平台与健康促进融媒体中心；协同能力上，构建儿童青少年常见病 ...

Core Viewpoint - The company, Lanzhou Manor Pasture Co., Ltd., is a leading player in the dairy industry in Northwest China, focusing on quality and market expansion strategies to enhance its brand presence and sales [2][4]. Company Overview - Lanzhou Manor Pasture Co., Ltd. engages in the production, processing, and sales of dairy products and dairy beverages, with a product range that includes pasteurized milk, sterilized milk, fermented milk, and other liquid dairy products under brands such as "Manor Pasture," "Holy Lake," and "Oriental Fresh Manor" [2][9]. - The company was established on April 25, 2000, and went public on October 31, 2017. Its main business revenue composition includes sterilized milk (37.04%), fermented milk (24.37%), and other dairy products [9]. Market Position - The company has established itself as a leading dairy product enterprise in Gansu and Qinghai, holding a market share of approximately 20% [2]. - The company has implemented a balanced development strategy that aligns market development with supply capabilities, focusing on product safety and freshness [2]. Marketing Strategies - In 2024, the company adopted integrated marketing strategies, leveraging tourism routes to promote new products and enhance market expansion through online and offline channels [3]. - The company has utilized social media platforms and KOLs to increase brand awareness and product visibility, particularly through the promotion of its "Old Lanzhou" product series [3]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 629 million yuan, a year-on-year decrease of 3.10%, while the net profit attributable to shareholders was -48.44 million yuan, reflecting a year-on-year increase of 59.08% [9]. - The company has distributed a total of 64.69 million yuan in dividends since its A-share listing, with cumulative distributions of 12.19 million yuan over the past three years [9]. Ownership and Governance - The company is a state-owned enterprise, ultimately controlled by the Gansu Provincial Government's State-owned Assets Supervision and Administration Commission [4].

Core Insights - The report continues to recommend innovative drugs and the related industry chain, highlighting the strong growth potential in the pharmaceutical sector through 2026 [1][4]. Investment Strategy - The investment strategy emphasizes the focus on the CXO sector, particularly in chemical CDMO, where Chinese companies hold significant advantages in talent, chemical capabilities, compliance production, and intellectual property protection [4]. - The report suggests that the upcoming JPM conference will provide updates on the operational progress of Chinese innovative drug companies, which have shown a long-term positive development trend [4]. - The recommended investment portfolio includes A-shares such as Mindray Medical, WuXi AppTec, and Aier Eye Hospital, as well as H-shares like Kangfang Biologics and WuXi Biologics [4][5]. Industry Performance - The pharmaceutical industry experienced a decline of 4.10% in December, underperforming the CSI 300 index by 6.38% [8]. - The report notes that the chemical pharmaceutical sector saw the largest declines among sub-sectors, with a drop of 5.80% [12]. Market Data - For the period from January to November 2025, the pharmaceutical manufacturing industry's total revenue was 220.65 billion yuan, reflecting a year-on-year decrease of 2.0% [7]. - The total retail sales of consumer goods reached 45.61 trillion yuan, with retail sales of Western and Chinese medicines amounting to 660.4 billion yuan, a year-on-year increase of 1.8% [7]. Regulatory Environment - The report discusses the impact of the U.S. "Biological Safety Act," which is expected to have a limited short-term effect on Chinese CXO companies, while emphasizing the need to monitor the long-term implications of international competition and regulatory changes [22]. Recent Drug Approvals - In December 2025, a total of 16 innovative drugs or biosimilars were approved for market entry, including six domestic and ten imported products [24][25].

Core Viewpoint - The company, Lanzhou Manor Pasture Co., Ltd., is actively expanding its market presence in the dairy industry while aligning with national policies on rural revitalization and ecological agriculture [2][4]. Group 1: Company Overview - Lanzhou Manor Pasture Co., Ltd. primarily engages in the production, processing, and sales of dairy products and dairy beverages, with a product range that includes pasteurized milk, sterilized milk, fermented milk, and various liquid dairy products under brands such as "Manor Pasture," "Holy Lake," and "Oriental Fresh Manor" [2][9]. - The company has established itself as a leading dairy producer in Gansu and Qinghai, holding a market share of 20% [2]. Group 2: Marketing and Sales Strategies - The company has implemented integrated marketing strategies, including promoting new products through tourism routes and leveraging social media platforms for brand awareness and sales [3]. - Online initiatives include developing a Gansu specialty store to boost low-temperature product sales, while offline efforts focus on expanding themed stations and specialty channels in cities like Tianshui and Lanzhou [3]. Group 3: Financial Performance - For the period from January to September 2025, the company reported a revenue of 629 million yuan, reflecting a year-on-year decrease of 3.1%, while the net profit attributable to shareholders was a loss of 48.44 million yuan, which is an increase of 59.08% compared to the previous year [9]. - The company has distributed a total of 64.69 million yuan in dividends since its A-share listing, with 12.19 million yuan distributed over the past three years [10]. Group 4: Shareholder and Market Dynamics - As of September 30, 2025, the number of shareholders decreased by 12.97% to 18,100, while the average circulating shares per person increased by 14.91% to 9,466 shares [9]. - The company is classified under several industry concepts, including domestic dairy, Gansu state-owned assets, biological safety, state-owned enterprise reform, and ecological agriculture [9].

Core Viewpoint - The company, Lanzhou Zhuangyuan Pasture Co., Ltd., is a leading player in the dairy industry in Northwest China, focusing on quality and market expansion strategies to enhance its brand presence and sales [2][4]. Company Overview - Lanzhou Zhuangyuan Pasture Co., Ltd. specializes in the production, processing, and sales of dairy products and milk beverages, with a product range that includes pasteurized milk, sterilized milk, fermented milk, and various liquid dairy products under brands such as "Zhuangyuan Pasture," "Shenghu," and "Dongfang Duoxian Zhuangyuan" [2][9]. - The company was established on April 25, 2000, and went public on October 31, 2017. Its main business revenue composition includes sterilized milk (37.04%), fermented milk (24.37%), and other dairy products [9]. Market Position and Strategy - The company has a market share of 20% in the dairy sector in Gansu and Qinghai provinces, positioning itself as a leading dairy enterprise in the region [2]. - The company has implemented a series of integrated marketing strategies, including collaborations with tourism routes and online promotions through KOLs and live streaming to enhance market reach and sales [3]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 629 million yuan, a year-on-year decrease of 3.10%, while the net profit attributable to shareholders was -48.44 million yuan, showing a year-on-year increase of 59.08% [9][10]. - The company has distributed a total of 646.93 million yuan in dividends since its A-share listing, with 12.19 million yuan distributed over the past three years [10]. Ownership and Governance - The company is a state-owned enterprise, ultimately controlled by the Gansu Provincial Government's State-owned Assets Supervision and Administration Commission [4]. - As a national-level agricultural industrialization leading enterprise, the company actively supports rural revitalization policies and engages in initiatives to increase farmers' income through various cooperative agreements [4].

Core Viewpoint - The event organized by the Daming County Health Bureau aimed to enhance public awareness of biological safety and risk prevention through a health education campaign and free medical services [1] Group 1: Event Overview - The Daming County Health Bureau collaborated with local hospitals to conduct a biological safety-themed health education and free medical service event in Wuyang Community [1] - The event included various health services such as acupuncture, physiotherapy, pulse taking, blood pressure and blood sugar measurement, health consultations, eye screenings, and guidance on medical usage [1] Group 2: Educational Content - The campaign provided education on the "Biological Safety Law of the People's Republic of China," transmission routes of winter infectious diseases, and prevention knowledge for common infectious diseases [1] - Participants received personalized health lifestyle recommendations based on professional assessments [1] Group 3: Community Impact - Approximately 150 individuals were served during the event, and over 200 promotional materials related to biological safety were distributed, receiving positive feedback from the community [1] - The Daming County Health Bureau plans to continue utilizing health resources to innovate promotional methods and expand outreach for ongoing biological safety and health law education [1]